alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 2365 Reported in Senate (RS)]

<DOC>

                                                       Calendar No. 388
116th CONGRESS
  1st Session
                                S. 2365

                          [Report No. 116-180]

  To amend the Indian Health Care Improvement Act to authorize urban 
  Indian organizations to enter into arrangements for the sharing of 
        medical services and facilities, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 31, 2019

 Mr. Udall (for himself, Mr. Moran, Mr. Tester, Mr. Rounds, Ms. Smith, 
 Ms. Duckworth, Ms. Sinema, and Ms. McSally) introduced the following 
  bill; which was read twice and referred to the Committee on Indian 
                                Affairs

                           December 18, 2019

               Reported by Mr. Hoeven, without amendment

_______________________________________________________________________

                                 A BILL

 
  To amend the Indian Health Care Improvement Act to authorize urban 
  Indian organizations to enter into arrangements for the sharing of 
        medical services and facilities, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Health Care Access for Urban Native 
Veterans Act of 2019''.

SEC. 2. SHARING ARRANGEMENTS WITH FEDERAL AGENCIES.

    Section 405 of the Indian Health Care Improvement Act (25 U.S.C. 
1645) is amended--
            (1) in subsection (a)(1), by inserting ``urban Indian 
        organizations,'' before ``and tribal organizations''; and
            (2) in subsection (c)--
                    (A) by inserting ``urban Indian organization,'' 
                before ``or tribal organization''; and
                    (B) by inserting ``an urban Indian organization,'' 
                before ``or a tribal organization''.
                                                       Calendar No. 388

116th CONGRESS

  1st Session

                                S. 2365

                          [Report No. 116-180]

_______________________________________________________________________

                                 A BILL

  To amend the Indian Health Care Improvement Act to authorize urban 
  Indian organizations to enter into arrangements for the sharing of 
        medical services and facilities, and for other purposes.

_______________________________________________________________________

                           December 18, 2019

                       Reported without amendment
```
Exhibit 4.1

 

DESCRIPTION OF THE REGISTRANT’S SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

As of December 31, 2019, Aridis Pharmaceuticals, Inc. had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) common stock, $0.0001 par value per share (“Common Stock”).

 

Unless the context otherwise requires, all references to “we”, “us”, the “Company”, or “Aridis” in this Exhibit 4.1 refer to Aridis Pharmaceuticals, Inc.

 

DESCRIPTION OF CAPITAL STOCK

 

The following description of our securities is intended as a summary only and is qualified in its entirety by reference to our amended and restated certificate of incorporation and bylaws, which are filed as exhibits to the annual report on Form 10-K of which this Exhibit 4.1 is a part.

 

Authorized Capitalization

 

Our authorized capital stock consists of 100,000,000 shares of Common Stock and 60,000,000 shares of preferred stock, $0.0001 par value per share (“Preferred Stock”) in one or more series. 

 

Transfer Agent and Registrar. The transfer agent for our Common Stock is Philadelphia Stock Transfer.

 

Listing. Our Common Stock is traded on the Nasdaq Capital Market under the symbol “ARDS.”

 

Common Stock

 

Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of our stockholders. Holders of our common stock have no cumulative voting rights. All shares of common stock offered hereby will, when issued, be fully paid and nonassessable, including shares of common stock issued upon the exercise of common stock warrants or subscription rights, if any.

 

Further, holders of our common stock have no preemptive or conversion rights or other subscription rights. Upon our liquidation, dissolution or winding- up, holders of our common stock are entitled to share in all assets remaining after payment of all liabilities and the liquidation preferences of any of our outstanding shares of preferred stock. Subject to preferences that may be applicable to any outstanding shares of preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our Board of Directors out of our assets which are legally available. Such dividends, if any, are payable in cash, in property or in shares of capital stock.

 

The holders of a majority of the shares of our capital stock, represented in person or by proxy, are necessary to constitute a quorum for the transaction of business at any meeting. If a quorum is present, an action by stockholders entitled to vote on a matter is approved if the number of votes cast in favor of the action exceeds the number of votes cast in opposition to the action, with the exception of the election of directors, which requires a plurality of the votes cast.
Page 1 of 1

IN THE UNITED STATES DISTRICT COURT FOR THE

NORTHERN DISTRICT OF FLORIDA

PENSACOLA DIVISION

DONALD JAMES HELMS,

 Petitioner,

vs. Case No. 3:10cv135/MCR/EMT

WARDEN MICHAEL BABCOCK, et al.,

 Respondents.

__________________________________/

O R D E R

This cause is before the court on Respondent’s answer (Doc. 14) to the petition for writ of

habeas corpus filed pursuant to 28 U.S.C. § 2241 (Doc. 1). Respondent seeks denial of the petition

for writ of habeas corpus and cites authority in support of denial. It appears that the interest of

justice would best be served by allowing Petitioner an opportunity to reply to the answer.

Accordingly, it is therefore ORDERED:

Petitioner shall reply to the answer (Doc. 14) within TWENTY (20) DAYS from the date

of docketing of this order.

DONE AND ORDERED this 6 day of July 2010. th

/s/ Elizabeth M. Timothy 

ELIZABETH M. TIMOTHY

UNITED STATES MAGISTRATE JUDGE
EXHIBIT 32

|   | 1. | The      Report fully complies with the requirements of section 13 (a) or 15 (d) of      the Securities Exchange Act of 1934,and |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The      information contained in the Report fairly presents, in all material      respects, the financial condition and result of operations of the      Company. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | /s/      William E. Luther                                                             |
|--------|----------------------------------------------------------------------------------------|
|   |      William      E. Luther                                   |
|   |      Chief      Executive Officer and Chief Financial Officer |
|   |      April      10, 2008                                      |
IN THE UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF FLORIDA

PENSACOLA DIVISION

TECHSHELL, INC.,

Plaintiff,

vs. CASE NO. 3:10cv154/RS-MD

HARD CANDY CASES, LLC;

SPECK PRODUCT DESIGN, INC.;

IPEARL, INC.; XGEAR, LLC;

CASE-MATE GEORGIA, LLC;

CASE-MATE INTERNATIONAL, LLC;

and CASE-MATE RETAIL, INC.,

Defendants.

___________________________________________/

AMENDED ORDER

Before me are Defendants’ Motion For Continuance Of May 9, 2011, Trial By

Four Months And Motion To Extend Discovery And Mediation Until April 30, 2011, 

(Doc. 135) and Plaintiff’s Motion For Clarification Regarding Expert Disclosures 

(Doc. 110).

IT IS ORDERED:

1. The Motion To Extend Mediation Until April 30, 2011, is denied as moot.

2. The discovery deadline is extended to April 30, 2011.

3. The parties shall file an amendment to the Joint Planning and Scheduling

Report to provide for disclosure and discovery of expert testimony

consistent with the discovery deadline of April 30, 2011. All other

deadlines dependent upon the discovery deadline are adjusted

accordingly. 
4. Trial is rescheduled for July 11, 2011, in Pensacola, Florida.

ORDERED on February 9, 2011.

/S/ Richard Smoak 

RICHARD SMOAK

UNITED STATES DISTRICT JUDGE
#### STATE v. LAWRENCE

No. 123 PC.

Case below: 40 N.C. App. 427.

Petition by Attorney General for discretionary review under G.S. 7A-31 denied 12 July 1979.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary

          - [Transmittal Nos. 08-08]

# AGENCY:

Department of Defense, Defense Security Cooperation Agency.

# ACTION:

Notice.

# SUMMARY:

The Department of Defense is publishing the unclassified text of a section 36(b)(1) arms sales notification. This is published to fulfill the requirements of section 155 of Public Law 104-164 dated 21 July 1996.

# FOR FURTHER INFORMATION CONTACT:

Ms. B. English, DSCA/DBO/CFM, (703) 601-3740.

The following is a copy of a letter to the Speaker of the House of Representatives, Transmittals 08-08 with attached transmittal, and policy justification.

Dated: October 11, 2007.

L.M. Bynum,

OSD Federal Register Liaison Officer, Department of Defense.

      ( print page 58829)          ( print page 58830)          ( print page 58831)    

BILLING CODE 5001-06-M

[FR Doc. 07-5115 Filed 10-16-07; 8:45 am]

BILLING CODE 5001-06-C
<PAGE>

                                                                   Exhibit 10.1

                  MODIFICATION OF LOAN AND SECURITY AGREEMENT


WHEREAS this agreement is in reference to a loan which is evidenced by an
instrument entitled LOAN AND SECURITY AGREEMENT ("AGREEMENT"), dated October
29, 1999, executed by and between LEE PHARMACEUTICALS as "BORROWER" and
FINOVA CAPITAL CORPORATION ("FINOVA"), as "LENDER".

NOW THEREFORE, it is agreed by the undersigned parties that the AGREEMENT
shall be amended in the following respect:


     In Section 2.8 of the Agreement, the term of this Agreement shall be
     extended to May 21, 2002.


Except as noted above, all the terms, conditions and provisions of said
AGREEMENT shall remain unchanged and in full force and effect.


Date: May 19, 2000

FINOVA CAPITAL CORPORATION               AGREED AND ACCEPTED:
                                         LEE PHARMACEUTICALS

BY:      FARHAD MOTIA                    BY:      RONALD G. LEE
    -----------------------                 ------------------------
    Farhad Motia, President                 Ronald G. Lee, President
#### R. B. Goodroe, plaintiff in error, *vs.*Thomas Neal, defendant in error.

By two judges.) — The Ordinance of 1865, suspending the Statutes of Limitations, was of force, *proprio vigore,*irrespective of any confirmation of it by the Convention of 1868. 5th March, 1872.

Ordinance of 1865. Limitation of Actions. Before Judge Johnson. Marion Superior Court. October Term, 1871.

The case is reported in the opinion.

W. B. Butt; M. H. Blanford, for plaintiff in error.

E. M. Miller; E. H. Worrill, for defendant.

*110Montgomery, Judge.

This was an action by defendant in error against plaintiff in error upon two promissory notes, payable December 25, 1859, and December 25, 1860, the suit not having been commenced before July 21, 1869. Defendant pleaded the Statute of Limitations, making the point that the Ordinance of 1865, suspending the Statutes of Limitations, had no force *suo proprio vigore,*and took effect only after the confirming Ordinance of the Convention of 1868 gave it vitality; and that before the latter Ordinance was passed, the statute had fully run ; and hence, under the principle laid down in *Calhoun vs. Kellogg,*41 Georgia Reports, 231, the plaintiff’s action was barred.

I know of no reason why the Ordinance of 1865 did not take effect *suo proprio vigore,*which does not apply with much greater force to any ordinance of the Convention of 1868. Hence, no confirmation of an ordinance of the former convention by the latter could possibly give it any greater force than it intrinsically possessed.

Judgment affirmed.
# CE2012380EN.01015401.xml

| 11.12.2012 | EN | Official Journal of the European Union | CE 380/154 |
| --- | --- | --- | --- |

11.12.2012

EN

Official Journal of the European Union

CE 380/154

---

Tuesday 7 June 2011Appointment of a Member of the Court of Auditors (H.G. Wessberg-SV)

P7_TA(2011)0246

European Parliament decision of 7 June 2011 on the nomination of H.G. Wessberg as a Member of the Court of Auditors (C7-0103/2011 – 2011/0803(NLE))

2012/C 380 E/24

(Consultation)

The European Parliament,

The European Parliament

| — | having regard to Article 286(2) of the Treaty on the Functioning of the EU, pursuant to which the Council consulted Parliament (C7-0103/2011), |
| --- | --- |

—

having regard to Article 286(2) of the Treaty on the Functioning of the EU, pursuant to which the Council consulted Parliament (C7-0103/2011),

| — | having regard to the fact that at its meeting of 24 May 2011 the Committee on Budgetary Control heard the Council's nominee for membership of the Court of Auditors, |
| --- | --- |

—

having regard to the fact that at its meeting of 24 May 2011 the Committee on Budgetary Control heard the Council's nominee for membership of the Court of Auditors,

| — | having regard to Rule 108 of its Rules of Procedure, |
| --- | --- |

—

having regard to Rule 108 of its Rules of Procedure,

| — | having regard to the report of the Committee on Budgetary Control (A7-0190/2011), |
| --- | --- |

—

having regard to the report of the Committee on Budgetary Control (A7-0190/2011),

| A. | whereas H.G. Wessberg fulfils the conditions laid down in Article 286(1) of the Treaty on the Functioning of the EU, |
| --- | --- |

A.

whereas H.G. Wessberg fulfils the conditions laid down in Article 286(1) of the Treaty on the Functioning of the EU,

| 1. | Delivers a favourable opinion on the nomination of H.G. Wessberg as a Member of the Court of Auditors; |
| --- | --- |

1.

Delivers a favourable opinion on the nomination of H.G. Wessberg as a Member of the Court of Auditors;

| 2. | Instructs its President to forward this decision to the Council and, for information, the Court of Auditors, the other institutions of the European Union and the audit institutions of the Member States. |
| --- | --- |

2.

Instructs its President to forward this decision to the Council and, for information, the Court of Auditors, the other institutions of the European Union and the audit institutions of the Member States.

---
#### STATE v. LINVILLE

No. 83 PC.

No. 38 (Spring Term).

Case below: 43 N.C. App. 204.

Petition by defendant for discretionary review under G.S. 7A-31 allowed 4 December 1979.
# C_2011221EN.01000501.xml

| 27.7.2011 | EN | Official Journal of the European Union | C 221/5 |
| --- | --- | --- | --- |

27.7.2011

EN

Official Journal of the European Union

C 221/5

---

Information communicated by Member States regarding closure of fisheries

2011/C 221/04

In accordance with Article 35(3) of Council Regulation (EC) No 1224/2009 of 20 November 2009 establishing a Community control system for ensuring compliance with the rules of the common fisheries policy (1), a decision has been taken to close the fishery as set down in the following table:

1

| Date and time of closure | 7.4.2011 |
| --- | --- |
| Duration | 7.4.2011-31.12.2011 |
| Member State | Spain |
| Stock or Group of stocks | USK/567EI. |
| Species | Tusk (Brosme brosme) |
| Zone | EU and international waters of V, VI and VII |
| Type(s) of fishing vessels | — |
| Reference number | 477997 |

Date and time of closure

7.4.2011

Duration

7.4.2011-31.12.2011

Member State

Spain

Stock or Group of stocks

USK/567EI.

Species

Tusk (Brosme brosme)

Brosme brosme

Zone

EU and international waters of V, VI and VII

Type(s) of fishing vessels

—

Reference number

477997

Web link to the decision of the Member State:

http://ec.europa.eu/fisheries/cfp/fishing_rules/tacs/index_en.htm

---

(1)  OJ L 343, 22.12.2009, p. 1.

1

---
# C_2009045EN.01S00301.xml

| 24.2.2009 | EN | Official Journal of the European Union | C 45/s3 |
| --- | --- | --- | --- |

24.2.2009

EN

Official Journal of the European Union

C 45/s3

---

NOTE TO THE READER

NOTE TO THE READER

The institutions have decided no longer to quote in their texts the last amendment to cited acts.

Unless otherwise indicated, references to acts in the texts published here are to the version of those acts currently in force.

---
Case 1:07-cv-02262-WHP Document 19-3 Filed 04/01/2008 Page 1 of 2
Case 1:07-cv-02262-WHP Document 19-3 Filed 04/01/2008 Page 2 of 2
<PAGE>

                                                                    EXHIBIT 99.1

                SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

                          INDEPENDENT AUDITORS' REPORT

To the Stockholders and Board of Directors of
 Infonet Services Corporation
El Segundo, California

     We have audited the consolidated financial statements of Infonet Services
Corporation and its subsidiaries as of March 31, 2001 and 2002, and for each of
the three years in the period ended March 31, 2002, and have issued our report
thereon dated June 10, 2002 (included elsewhere in this Annual Report on Form
10-K). Our audits also included the financial statement schedule listed in Item
14. This financial statement schedule is the responsibility of the Company's
management. Our responsibility is to express an opinion based on our audits. In
our opinion, such financial statement schedule, when considered in relation to
the basic consolidated financial statements taken as a whole, presents fairly in
all material respects the information set forth therein.

/s/ DELOITTE & TOUCHE LLP
-------------------------
Deloitte & Touche LLP

Los Angeles, California
June 10, 2002

                                                                     SCHEDULE II

                 INFONET SERVICES CORPORATION AND SUBSIDIARIES

            VALUATION AND QUALIFYING ACCOUNTS (DOLLARS IN THOUSANDS)

<TABLE>
<CAPTION>
                         BALANCE AT     CHARGED TO      CHARGED                      BALANCE AT
                         BEGINNING      COSTS AND       TO OTHER                       END OF
DESCRIPTION              OF PERIOD      EXPENSES        ACCOUNTS      DEDUCTIONS       PERIOD
-----------              ---------      ----------      --------      ----------     ----------
<S>                      <C>            <C>             <C>           <C>            <C>
Allowances for doubtful
 accounts and customer
 credits
 2000..................    3,876          1,381          3,128          21               8,364
 2001..................    8,364          2,282          3,296          87              13,855
 2002..................   13,855            759            436         120              14,930
</TABLE>
Exhibit B





As of March 1, 2005 there are Fifteen Million Four Hundred Fourteen Thousand One Hundred Seventeen (15,414,117) shares of common stock outstanding, and no shares of preferred stock have been issued. Additionally, there are outstanding: 1) Purchase warrants for One Million Thirty Six Thousand Three Hundred Eighty Nine (1,036,389) common shares exercisable at Forty Five cents ($0.45) on or before September 19, 2005, 2) Options for 20,000 common shares exercisable at Twenty Nine cents ($0.29) on or before March 3, 2014, and 3) Options for 300,000 shares exercisable at Twenty Two cents ($0.22) on or before December 31, 2014. On a fully diluted basis, the common shares outstanding are Sixteen Million Eight Hundred Thousand Five Hundred and Six (16,770,506).
Exhibit 23b.**Consent of Independent Registered Public Accounting Firm**We consent to the incorporation by reference in registration statements on Form S-8 (No. 333-41668,No. 333-74554, and No. 124682 (as amended)) and on Form S-3 (No. 333-116747 (as amended)) ofTrinsic, Inc. of our report dated March 31, 2006, relating to our audit of the consolidatedfinancial statements of Trinsic, Inc. included in this Annual Report on Form 10-K for the yearended December 31, 2005. Our report dated March 31, 2006 relating to the consolidated financialstatements includes an emphasis paragraph relating to an uncertainty as to the Company’s ability tocontinue as a going concern./s/ Carr, Riggs & Ingram, LLCMontgomery, Alabama
**Exhibit
      32.2**




**Certification
      Pursuant to**


**18
      U.S.C. Section 1350**


**As
      Adopted Pursuant to**


**Section
      906 of the Sarbanes-Oxley Act of 2002**








In
      connection with the Annual Report of GFR Pharmaceuticals, Inc. (the “Company”)
      on Form 10-KSB for the year ended December 31, 2006 as filed with the Securities
      and Exchange Commission on the date hereof (the “Report”), I, Zhi Dong Wang,
      Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as
      adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, based on my
      knowledge:





(1)
            The
                Report fully complies with the requirements of Section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934;
                and





(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company.








April
      12,
      2007





GFR
      PHARMACEUTICALS, INC.








*/s/
      Zhi Dong Wang*


Zhi
      Dong
      Wang, Chief Financial Officer